Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 12 |
NetGPI | no | yes: 0, no: 12 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005634 | nucleus | 5 | 2 |
GO:0005654 | nucleoplasm | 2 | 2 |
GO:0005737 | cytoplasm | 2 | 2 |
GO:0005930 | axoneme | 2 | 2 |
GO:0032838 | plasma membrane bounded cell projection cytoplasm | 4 | 2 |
GO:0043226 | organelle | 2 | 2 |
GO:0043227 | membrane-bounded organelle | 3 | 2 |
GO:0043229 | intracellular organelle | 3 | 2 |
GO:0043231 | intracellular membrane-bounded organelle | 4 | 2 |
GO:0097014 | ciliary plasm | 5 | 2 |
GO:0099568 | cytoplasmic region | 3 | 2 |
GO:0110165 | cellular anatomical entity | 1 | 2 |
Related structures:
AlphaFold database: Q4QA01
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_PCSK_SKI1_1 | 165 | 169 | PF00082 | 0.409 |
DEG_APCC_DBOX_1 | 238 | 246 | PF00400 | 0.520 |
DEG_APCC_DBOX_1 | 38 | 46 | PF00400 | 0.193 |
DEG_SPOP_SBC_1 | 118 | 122 | PF00917 | 0.611 |
DOC_CDC14_PxL_1 | 1 | 9 | PF14671 | 0.535 |
DOC_CKS1_1 | 95 | 100 | PF01111 | 0.514 |
DOC_CYCLIN_RxL_1 | 162 | 170 | PF00134 | 0.408 |
DOC_MAPK_MEF2A_6 | 39 | 46 | PF00069 | 0.401 |
DOC_MAPK_NFAT4_5 | 39 | 47 | PF00069 | 0.193 |
DOC_PP4_FxxP_1 | 95 | 98 | PF00568 | 0.456 |
DOC_USP7_MATH_1 | 101 | 105 | PF00917 | 0.625 |
DOC_USP7_MATH_1 | 118 | 122 | PF00917 | 0.674 |
DOC_USP7_MATH_1 | 142 | 146 | PF00917 | 0.192 |
DOC_USP7_MATH_1 | 211 | 215 | PF00917 | 0.535 |
DOC_USP7_MATH_1 | 254 | 258 | PF00917 | 0.485 |
DOC_USP7_MATH_1 | 85 | 89 | PF00917 | 0.317 |
DOC_WW_Pin1_4 | 114 | 119 | PF00397 | 0.732 |
DOC_WW_Pin1_4 | 123 | 128 | PF00397 | 0.456 |
DOC_WW_Pin1_4 | 147 | 152 | PF00397 | 0.266 |
DOC_WW_Pin1_4 | 26 | 31 | PF00397 | 0.479 |
DOC_WW_Pin1_4 | 94 | 99 | PF00397 | 0.454 |
LIG_14-3-3_CanoR_1 | 39 | 45 | PF00244 | 0.295 |
LIG_14-3-3_CanoR_1 | 53 | 61 | PF00244 | 0.298 |
LIG_14-3-3_CanoR_1 | 63 | 68 | PF00244 | 0.375 |
LIG_14-3-3_CanoR_1 | 80 | 90 | PF00244 | 0.396 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.518 |
LIG_FHA_1 | 11 | 17 | PF00498 | 0.421 |
LIG_FHA_1 | 54 | 60 | PF00498 | 0.339 |
LIG_FHA_2 | 182 | 188 | PF00498 | 0.350 |
LIG_LIR_Gen_1 | 227 | 237 | PF02991 | 0.535 |
LIG_LIR_Nem_3 | 227 | 232 | PF02991 | 0.538 |
LIG_PCNA_PIPBox_1 | 160 | 169 | PF02747 | 0.321 |
LIG_SH2_PTP2 | 229 | 232 | PF00017 | 0.533 |
LIG_SH2_SRC | 229 | 232 | PF00017 | 0.592 |
LIG_SH2_STAT5 | 166 | 169 | PF00017 | 0.399 |
LIG_SH2_STAT5 | 229 | 232 | PF00017 | 0.539 |
LIG_SH2_STAT5 | 35 | 38 | PF00017 | 0.438 |
LIG_SUMO_SIM_anti_2 | 86 | 91 | PF11976 | 0.193 |
LIG_SUMO_SIM_par_1 | 126 | 131 | PF11976 | 0.359 |
LIG_TYR_ITIM | 164 | 169 | PF00017 | 0.321 |
MOD_CK1_1 | 121 | 127 | PF00069 | 0.616 |
MOD_GlcNHglycan | 104 | 107 | PF01048 | 0.647 |
MOD_GlcNHglycan | 123 | 126 | PF01048 | 0.673 |
MOD_GlcNHglycan | 144 | 147 | PF01048 | 0.375 |
MOD_GlcNHglycan | 157 | 160 | PF01048 | 0.391 |
MOD_GlcNHglycan | 20 | 24 | PF01048 | 0.472 |
MOD_GlcNHglycan | 213 | 216 | PF01048 | 0.579 |
MOD_GlcNHglycan | 224 | 227 | PF01048 | 0.482 |
MOD_GlcNHglycan | 83 | 86 | PF01048 | 0.389 |
MOD_GlcNHglycan | 99 | 102 | PF01048 | 0.478 |
MOD_GSK3_1 | 110 | 117 | PF00069 | 0.627 |
MOD_GSK3_1 | 119 | 126 | PF00069 | 0.658 |
MOD_GSK3_1 | 177 | 184 | PF00069 | 0.358 |
MOD_GSK3_1 | 218 | 225 | PF00069 | 0.579 |
MOD_GSK3_1 | 3 | 10 | PF00069 | 0.556 |
MOD_GSK3_1 | 59 | 66 | PF00069 | 0.412 |
MOD_GSK3_1 | 81 | 88 | PF00069 | 0.370 |
MOD_GSK3_1 | 93 | 100 | PF00069 | 0.388 |
MOD_N-GLC_1 | 26 | 31 | PF02516 | 0.505 |
MOD_N-GLC_1 | 33 | 38 | PF02516 | 0.450 |
MOD_NEK2_1 | 102 | 107 | PF00069 | 0.508 |
MOD_NEK2_1 | 128 | 133 | PF00069 | 0.437 |
MOD_NEK2_1 | 167 | 172 | PF00069 | 0.398 |
MOD_NEK2_1 | 59 | 64 | PF00069 | 0.356 |
MOD_NEK2_1 | 7 | 12 | PF00069 | 0.490 |
MOD_PIKK_1 | 10 | 16 | PF00454 | 0.396 |
MOD_PIKK_1 | 219 | 225 | PF00454 | 0.554 |
MOD_PIKK_1 | 54 | 60 | PF00454 | 0.321 |
MOD_PKA_2 | 110 | 116 | PF00069 | 0.571 |
MOD_PKA_2 | 177 | 183 | PF00069 | 0.397 |
MOD_PKA_2 | 40 | 46 | PF00069 | 0.296 |
MOD_Plk_1 | 19 | 25 | PF00069 | 0.512 |
MOD_Plk_1 | 254 | 260 | PF00069 | 0.513 |
MOD_Plk_1 | 85 | 91 | PF00069 | 0.193 |
MOD_Plk_4 | 40 | 46 | PF00069 | 0.280 |
MOD_Plk_4 | 85 | 91 | PF00069 | 0.219 |
MOD_ProDKin_1 | 114 | 120 | PF00069 | 0.728 |
MOD_ProDKin_1 | 123 | 129 | PF00069 | 0.451 |
MOD_ProDKin_1 | 147 | 153 | PF00069 | 0.266 |
MOD_ProDKin_1 | 26 | 32 | PF00069 | 0.472 |
MOD_ProDKin_1 | 94 | 100 | PF00069 | 0.464 |
TRG_DiLeu_BaLyEn_6 | 124 | 129 | PF01217 | 0.404 |
TRG_ENDOCYTIC_2 | 166 | 169 | PF00928 | 0.321 |
TRG_ENDOCYTIC_2 | 229 | 232 | PF00928 | 0.543 |
TRG_NES_CRM1_1 | 187 | 200 | PF08389 | 0.384 |
TRG_Pf-PMV_PEXEL_1 | 247 | 251 | PF00026 | 0.472 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1I922 | Leptomonas seymouri | 62% | 100% |
A0A0S4IMZ1 | Bodo saltans | 29% | 100% |
A0A0S4IRG3 | Bodo saltans | 29% | 100% |
A0A1X0NNH1 | Trypanosomatidae | 37% | 100% |
A0A3Q8ICG2 | Leishmania donovani | 93% | 100% |
A0A422NXA4 | Trypanosoma rangeli | 37% | 100% |
A2AS55 | Mus musculus | 27% | 73% |
A4HE28 | Leishmania braziliensis | 81% | 100% |
A4I1D4 | Leishmania infantum | 93% | 100% |
C9ZKX0 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 30% | 100% |
E9AXH1 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 92% | 100% |
Q6P6B7 | Homo sapiens | 28% | 73% |
V5BBP8 | Trypanosoma cruzi | 37% | 100% |